Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure
Indonesia National Agency for Drug and Food Control, BPOM, Approved QDENGA(TAK-003) for Use in Individuals Six Years to 45 Years of Age1 QDENGAis the Only Dengue Vaccine Approved in Indonesia for Use